272 Arming pluripotent stem cell-derived lymphocytes with a suite of synthetic receptors enables scalable manufacturing and enhanced persistence and potency for potential off-the-shelf immunotherapy
Dillon K. Jarrell, Samantha DO’Hara, Cassidy Arnold, Andrew M. Scharenberg(CTI BioPharma (Italy)), Ryan Crisman, David Vereide, Ashley Yingst, Ryan Koning, Ryan Larson(CTI BioPharma (United States))
Cited by 0
Related Papers
ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology
|Nature|2001|897
TRPM4 Is a Ca2+-Activated Nonselective Cation Channel Mediating Cell Membrane Depolarization
|Cell|2002|751
A Unified Nomenclature for the Superfamily of TRP Cation Channels
|Molecular Cell|2002|679